Exploring the complexities of gene therapy, InfinixBio is at the forefront of assessing and managing immunogenicity to enhance therapy safety and effectiveness. Our expert team specializes in comprehensive immunogenicity assessments, utilizing cutting-edge bioanalytical techniques to study immune responses across various AAV serotypes. #GeneTherapy #BiotechInnovation #InfinixBio
InfinixBio’s Post
More Relevant Posts
-
Learn about the role of immune responses and their impact on the immunogenicity, safety and efficacy of AAV-mediated gene therapy from experts in the field! #GeneTherapy #Webinar #NaturePortfolio #AAVgenetherapy #Immunogenicity #ComplementingLifeScience https://hubs.ly/Q02CZHrM0
To view or add a comment, sign in
-
Advancing cell and gene therapies (CGTs) globally presents unique hurdles at every step, and Labcorp has the experience and capabilities to help you overcome them. In a recent presentation for the Korea Biomedicine Industry Association (KoBIA), Maryland Rosenfeld Franklin, PhD, vice president and enterprise head of CGT at Labcorp, discussed some of these challenges and explored their solutions. Watch the recorded webinar to learn more. #CellandGeneTherapy #CellTherapy #GeneTherapy
ON-DEMAND WEBINAR: Key challenges and lab solutions in your global cell and gene therapy trials, Mar. 20, 2024 | Labcorp
share.postbeyond.com
To view or add a comment, sign in
-
Associate Director, Proposal Management at Labcorp | Early Development | Enterprise Client Solutions
Advancing cell and gene therapies (CGTs) globally presents unique hurdles at every step, and Labcorp has the experience and capabilities to help you overcome them. In a recent presentation for the Korea Biomedicine Industry Association (KoBIA), Maryland Rosenfeld Franklin, PhD, vice president and enterprise head of CGT at Labcorp, discussed some of these challenges and explored their solutions. Watch the recorded webinar to learn more. #CellandGeneTherapy #CellTherapy #GeneTherapy
ON-DEMAND WEBINAR: Key challenges and lab solutions in your global cell and gene therapy trials, Mar. 20, 2024 | Labcorp
share.postbeyond.com
To view or add a comment, sign in
-
Check out this article on the groundbreaking research in gene therapy for congenital deafness! 🧬👂 The study demonstrates the effectiveness of this innovative treatment, offering hope for those affected. #GeneTherapy #CongenitalDeafness #MedicalAdvancements #feypsv
To view or add a comment, sign in
-
Two weeks ago, Nature Research Custom Media hosted our insightful webinar on AAV Safety and Potency: Exploring the Analytical Maze of Gene Therapy. It was a rich discussion on immune responses and their impact on efficacy and safety. If you missed the live event, don't worry! You still have the opportunity to participate in this important conversation. Register now to access the webinar on demand and catch up on valuable information that could make a difference in your work in gene therapy. #GeneTherapy #Webinar #NaturePortfolio #AAVgenetherapy #Immunogenicity #ComplementingLifeScience #AnswersinLifeScience https://hubs.ly/Q02zPg1q0
ON-DEMAND WEBINAR AAV safety and potency: exploring the analytical maze of gene therapy
svarlifescience.com
To view or add a comment, sign in
-
Advancing cell and gene therapies (CGTs) globally presents unique hurdles at every step, and Labcorp has the experience and capabilities to help you overcome them. In a recent presentation for the Korea Biomedicine Industry Association (KoBIA), Maryland Rosenfeld Franklin, PhD, vice president and enterprise head of CGT at Labcorp, discussed some of these challenges and explored their solutions. Watch the recorded webinar to learn more. #CellandGeneTherapy #CellTherapy #GeneTherapy
ON-DEMAND WEBINAR: Key challenges and lab solutions in your global cell and gene therapy trials, Mar. 20, 2024 | Labcorp
share.postbeyond.com
To view or add a comment, sign in
-
Advancing cell and gene therapies (CGTs) globally presents unique hurdles at every step, and Labcorp has the experience and capabilities to help you overcome them. In a recent presentation for the Korea Biomedicine Industry Association (KoBIA), Maryland Rosenfeld Franklin, PhD, vice president and enterprise head of CGT at Labcorp, discussed some of these challenges and explored their solutions. Watch the recorded webinar to learn more. #CellandGeneTherapy #CellTherapy #GeneTherapy
ON-DEMAND WEBINAR: Key challenges and lab solutions in your global cell and gene therapy trials, Mar. 20, 2024 | Labcorp
share.postbeyond.com
To view or add a comment, sign in
-
In this interactive roundtable—the first in a three-part series—our team discusses key opportunities, scientific innovations and insights driving acceleration of preclinical gene therapy programs to IND/CTA and beyond. Watch the roundtable here #GeneTherapy #PrecisionMedicine
Key Considerations for Driving Gene Therapy Programs Successfully Through IND/CTA and Beyond, Oct. 24, 2023 | Labcorp
learn-more.com
To view or add a comment, sign in
-
Exciting advancements in #haemophilia treatment! In recent decades, the life expectancy of people with haemophilia (PwH) has improved considerably thanks to efficient and safe treatment methods Gene therapy offers hope by correcting defective genes, potentially eliminating the need for frequent factor infusions. Learn more about this ground-breaking approach and its implications for therapy monitoring online 👉 https://lnkd.in/duRF39hw #sysmex #haemostasis
To view or add a comment, sign in
-
Are you interested in learning more about: 🦠 Overcoming challenges in the industrialisation of iPSC-derived therapies? 🏥 UK patient referral pathways for gene therapy and CAR-T? 📝 How to develop a robust Target Product Profile (TPP) for your #ATMP? Take a look at our webinar recordings to hear from the experts at CGT Catapult addressing the key topics above and many more relating to the #cell and #gene therapy industry: https://buff.ly/3uE5HLS #CellTherapy #GeneTherapy #AdvancedTherapies #Innovation #Webinars
Webinar recordings
ct.catapult.org.uk
To view or add a comment, sign in
1,673 followers